AutoGenomics Launches Familial Mediterranean Fever Panel, Plans FDA Submission
January 25, 2011
AutoGenomics Launches Familial Mediterranean Fever Panel, Plans FDA Submission
The firm expects to obtain a CE Mark for the assay later this quarter, and plans to eventually submit the panel to the US Food and Drug Administration for 510(k) clearance.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Nanosphere Will Submit Troponin Assay to FDA This Year, Expand European Launch
May 3, 2011 / BioArray News - PGXL, AutoGenomics Partner on Personalized Medicine
April 1, 2011 / GenomeWeb Daily News - In 2010, Array Makers Saw CGH Become the Standard in Cytogenetics, Prepared for Next Wave of GWAS
January 4, 2011 / BioArray News - Agendia Moving to Larger Lab to Keep Pace with Growing MammaPrint Testing Volume
August 11, 2010 / Pharmacogenomics Reporter - Roche NimbleGen Seeks GMP Compliance for Arrays as Step Toward FDA Submission
April 7, 2010 / GenomeWeb Daily News